[Discussion Points] NCDs-related Cross-project “Lessons and Challenges Drawn from NCDs Responses in Local Governments and Future Visions” (June 17, 2024)
date : 8/19/2024
Tags: Cardiovascular Diseases, Kidney Disease, NCDs, Obesity
The English version of the report has been published. (August 19, 2024)
Health and Global Policy Institute (HGPI) formulated “Lessons and Challenges Drawn from NCDs Responses in Local Governments and Future Visions.”
HGPI held the meeting ”The 1st NCDs Meeting in Kyushu” on December 7th 2023 and “The 2nd Meeting on Non-Communicable Diseases (NCDs) in Hokkaido and Tohoku” on March 15th 2024.
This meeting aimed at enhancing the understanding of NCDs, which require intervention and management across sectors in the community and workplaces. The meeting also discussed how NCDs measures should be tailored to local conditions and characteristics, as well as to promote the horizontal development of policies across the community.
HGPI has crystallized the discussion points related to topics that were discussed by participants on these meeting as well as their future prospects.
Discussion point 1: Cardio-renal-metabolic conditions, obesity, and related risk factors can be viewed as interrelated conditions. Rather than advancing regional control measures that target individual conditions, it will be necessary to establish systems using a more integrated approach that spans prevention and treatment to rehabilitation.
Discussion point 2: To improve uptake for routine and specific medical checkups, adopt methods of recommending checkups and providing explanations that reflect the circumstances of the people receiving them.
Discussion point 3: To encourage people whose checkup results require follow-up or more detailed testing to visit health institutions for secondary examinations, it will be important to have conversations that are in line with their lifestyles as well as to eliminate obstacles to medical examinations.
Discussion point 4: To ensure follow-up examinations provided after medical checkups are of high quality, and to enable family doctors to be able to provide referrals to and collaborate with specialists at the right times, it will be necessary to standardize care, to disseminate diagnostic and referral criteria, and to establish networks that facilitate healthcare collaboration.
Discussion point 5: The uneven geographical distribution of specialists results in cases where the windows for early detection are missed, so access to specialists should be improved through healthcare digital transformation (DX).
Discussion point 6: Measures for lifestyle disease control should include measures to reinforce the capacities of prefectural and municipal officials and to promote collaboration among them.
Discussion point 7: In each municipality, public health centers play key roles in cross-cutting collaboration that spans multiple diseases, and their functions should be reinforced.
Discussion point 8: Ensuring smooth collaboration among public health centers, prefectural governments, and municipal governments will be important. Doing so will require establishing systems for collaboration that are centered on public health centers and that involve stakeholders in the region.
Discussion point 9: In addition to measures limited to the public sector, there are examples in which cooperating with the private sector enhanced measures for lifestyle diseases. Cooperation among industry, Government, and academia is important.
Discussion point 10: Expectations are high for a population approach taken through stronger collaboration between community health and occupational health.
Discussion point 11: Obesity control is becoming more important for preventing the exacerbation of other diseases, but obesity measures at the municipal level are generally limited to metabolic syndrome. Obesity awareness must be expanded.
Discussion point 12: A system must be established that allows people to access the right treatment and support that is suited to the policy stage for each disease. Systems for intra-regional collaboration that are designed in a manner that they cut across diseases should also be established.
Discussion point 13: Lifestyle disease control requires collaboration that involves various stakeholders, that encompasses a life course perspective, and that takes aspects related to socioeconomics and welfare into account.
For details, please see the PDF linked below.
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Recommendations on Strategic Investments in Policies for Brain Health to Revitalize Japan: Hopes for the New Administration (December 1, 2025)
- [Announcement] HGPI Endorses the “Belém Health Action Plan” (November 14, 2025)
- [Announcement] HGPI Joins Global Green and Healthy Hospitals (August 1, 2023)
- [Research Report] AMR Policy Update #2: WHO’s First Report on Fungal Infection—Bridging the Gap Between Clinical Practice and R&D
Featured Posts
-
2025-12-09
[Event Report] Special Seminar “Rising to New Challenges in Health Sciences for Future Society: Novel Developments in the Field of Epilepsy in Japan and Globally” Belgium Pavilion Special Seminar, World Expo 2025 Osaka, Kansai (September 18, 2025)
-
2025-12-11
[Event Report] Core Components of Universal Health Coverage (UHC): Achieving “Healthcare Without Financial Hardship” in Asia-Pacific and Japan (December 5, 2025)
-
2025-12-12
[Registration Open] Meaningful Involvement Promotion Project Urgent Symposium “The New Takaichi Administration and Central Social Insurance Medical Council Reform – Ensuring Patients’ Voices are Heard” (January 22, 2026)
-
2025-12-12
[Registration Open] (Webinar) The 140th HGPI Seminar “Early Detection to Reduce COPD Disease Burden: Connecting Clinical Frontiers with Health Policy” (January 27, 2026)
-
2025-12-16
[Discussion Points] Policy Dialogue “Considering Comprehensive Genomic Profiling from the Perspective of Patient Access: Utilizing the Medical Service Fee Reimbursement System and the Mixed Medical Services Program to Meet the Needs of Today” (November 28, 2025)



